BYAH // Park Ha Biological Technology Co. Ltd. (Class A)
ANR <GO> NASDAQ RQD COCKPIT → CIK 0001986247 ↗ Consumer Discretionary • Package Goods/Cosmetics
$2.30 ▲ +0.04
(+1.71%)
MKT CAP: $7.9M • VOL: 2.2K
52W L $2 52W H $158
ROARABLE / RQD
D • 45/100
PIOTROSKI
5 / 9
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$2
MEDIAN
$3
MEAN
$3
HIGH
$3
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE BYAH TAPE
BYAH // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $2.78 | $2.64 | 2025-02-14 | $2.09 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $2.90 | $2.71 | 2025-02-06 | $2.16 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $2.62 | $2.53 | 2025-01-29 | $2.21 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $2.35 | — | 2025-01-17 | $2.25 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $2.02 | $2.18 | 2025-01-09 | $2.05 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $2.74 | $2.39 | 2024-12-18 | $2.00 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $2.23 | $2.32 | 2024-12-04 | $2.14 | -4.3% | 48% | C |